On Monday, Outlook Therapeutics Inc (NASDAQ: OTLK) opened higher 11.84% from the last session, before settling in for the closing price of $1.52. Price fluctuations for OTLK have ranged from $0.87 to $12.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -25.00% over the last five years. Company’s average yearly earnings per share was noted -2.19% at the time writing. With a float of $15.23 million, this company’s outstanding shares have now reached $23.41 million.
The firm has a total of 24 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Outlook Therapeutics Inc (OTLK) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Outlook Therapeutics Inc is 35.60%, while institutional ownership is 35.70%. The most recent insider transaction that took place on Sep 26 ’24, was worth 28,446. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $5.69, taking the stock ownership to the 5,946 shares. Before that another transaction happened on Mar 28 ’24, when Company’s Director bought 1,882 for $11.82, making the entire transaction worth $22,242. This insider now owns 5,049 shares in total.
Outlook Therapeutics Inc (OTLK) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.19% per share during the next fiscal year.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Check out the current performance indicators for Outlook Therapeutics Inc (OTLK). In the past quarter, the stock posted a quick ratio of 1.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.75, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -2.37 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
Analysing the last 5-days average volume posted by the [Outlook Therapeutics Inc, OTLK], we can find that recorded value of 1.82 million was better than the volume posted last year of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 16.07%. Additionally, its Average True Range was 0.47.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 10.60%, which indicates a significant decrease from 18.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 445.12% in the past 14 days, which was higher than the 181.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.8998, while its 200-day Moving Average is $7.0462. Now, the first resistance to watch is $1.8763. This is followed by the second major resistance level at $2.0527. The third major resistance level sits at $2.2258. If the price goes on to break the first support level at $1.5268, it is likely to go to the next support level at $1.3537. Should the price break the second support level, the third support level stands at $1.1773.
Outlook Therapeutics Inc (NASDAQ: OTLK) Key Stats
There are currently 23,656K shares outstanding in the company with a market cap of 40.21 million. Presently, the company’s annual sales total 0 K according to its annual income of -58,980 K. Last quarter, the company’s sales amounted to 0 K and its income totaled 44,410 K.
